UnitedHealth Group (UNH) Shares Rise on Strong Q3 Results and Ra

UnitedHealth Group (UNH) raised its full-year profit forecast to at least $20.50 per share, up from $19.50-$20, after Q3 earnings beat estimates. The stock jumped 5% in premarket trading. The company's turnaround plan is showing progress, with lower medical costs boosting profits. Year-to-date, the stock is up 14%.

UnitedHealth Group Incorporated updated its earnings guidance for 2026, projecting net earnings of over $17.65 billion and diluted earnings per share of at least $19.50, according to the company.

UnitedHealth Group (UNH) shares rose 4.5% premarket after beating Q3 earnings estimates ($4.69 vs. $4.14 expected) and raising its 2026 EPS outlook to at least $20.50. Revenue fell to $112.7B from $113.2B. Cost management and membership changes drove the results, with Medicare Advantage and employer plans seeing declines. CEO credited 'discipline and execution'.

UnitedHealth Group (UNH) shares rose 2.24% premarket after Q3 earnings beat estimates, with adjusted EPS of $4.69 and revenue of $112.7B. Revenue declined YoY due to Medicare Advantage membership loss. The company improved its 2026 EPS outlook to at least $20.50 adjusted and $19.50 GAAP.

UnitedHealth Group (UNH) reported Q3 2026 earnings of $4.69 per share, beating estimates, and raised its full-year earnings guidance to at least $19.50 per share. Revenue declined 0.4% YoY to $112.7B but exceeded expectations. The company offers a 2.4% dividend yield with a 58% payout ratio and a 3-year dividend growth rate of 10.9%. UNH's GF Score is 81/100, indicating strong fundamentals, particularly in profitability and momentum.

UnitedHealth Group (UNH) raised its 2026 earnings guidance to at least $20.50 per share after Q3 adjusted earnings of $4.69 per share beat estimates. Shares rose 4.5% in pre-market trading. Improvements came from better medical cost controls and Optum's performance, despite revenue declines and membership reductions.